Ligand profile
KEK
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_04610 — 2-hydroxy-6-oxononadienedioate/2-hydroxy-6- oxononatrienedioate hydrolase
Identifiers
Database identifiers and provenance.
- Ligand ID
KEK- PDB
2wue- UniProt (similar protein)
P9WNH5- Target protein
- KP13_04610
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 74.3
- −1 ≤ LogP ≤ 5 1.35
- MW ≤ 500 Da 293.7
- LogP ≤ 5 1.35
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 74.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[C@H](\C=C\C(=O)C(=O)[O-])C(=O)CCc1ccccc1ClC[C@H](\C=C\C(=O)C(=O)[O-])C(=O)CCc1ccccc1Cl
InChI=1S/C15H15ClO4/c1-10(6-8-14(18)15(19)20)13(17)9-7-11-4-2-3-5-12(11)16/h2-6,8,10H,7,9H2,1H3,(H,19,20)/p-1/b8-6+/t10-/m1/s1InChI=1S/C15H15ClO4/c1-10(6-8-14(18)15(19)20)13(17)9-7-11-4-2-3-5-12(11)16/h2-6,8,10H,7,9H2,1H3,(H,19,20)/p-1/b8-6+/t10-/m1/s1
OXPYJYFFTOKNRF-QEHWCHDUSA-MOXPYJYFFTOKNRF-QEHWCHDUSA-M
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand KEK →
- PDB RCSB structure 2wue →
- UniProt UniProt P9WNH5 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “KEK”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04610.
PDB 22
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).